High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth

VANCOUVER, BC, March 30, 2015 (GLOBE NEWSWIRE) — via PRWEB – According to a recently published report by iData Research (, the hernia repair market will continue to dominate the European soft tissue reinforcement and regeneration market. Growth is occurring primarily due to increasing numbers of ventral hernias, and the adoption of expensive biologics to treat them.

“The significantly large market share represented by ventral hernia repair devices is due to a generally high ASP. We’re seeing a growing use of expensive biologics,” explains Dr. Kamran Zamanian, CEO of iData. “These biologic devices are considerably more expensive than their synthetic counterparts. A ventral hernia is fairly large and requires more material to treat than an inguinal hernia. This coupled with high prices results in a high market value.”

The market has been growing alongside increases in the general incidence of hernias throughout Europe. However, although ventral hernia repair represents the majority of the total hernia repair market’s value, inguinal hernia procedures more than double ventral hernia procedures.

Other key findings from the 2015 edition of the iData Research report entitled European Markets for Soft Tissue Reinforcement and Regeneration:

Increased Need for Hernia Repair

The rising population of elderly and obese individuals will contribute to continuous increases in the number of hernia repair procedures performed. This, in turn, will lead to demand for all types of hernia repair devices.


Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button